Boryung Corporation

₩8,530As of Sun 8 Nov 2026, 12:00 UTC
KRX:003850Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 1.51%
Div yield 1.88%
ROE 14.38%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM 5.939
TSR TTM (1.65%)
Mkt cap ₩717.6B
ROIC 5.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,204
(3.82%)
(87.84%)
Buy 12|7|6|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
93.21
93.80
89.42
92.27
12.64%
3.78%
(4.03%)
3.67%
Revenue₩B
57.86
57.61
60.73
63.25
16.14%
10.30%
11.29%
11.08%
Peers (US$529.1M)
Cap (US$)
PE
612.0M
10.54x
499.0M
3.720x
529.0M
169.8x
Capital
TTM
5Y
10Y
Leveragex
3.803
0.242
0.226
EBIT/Intx
0.159
1.069
0.955
Own earn%
(117.79)
(164.75)
(158.08)
Sh yield%
20.34
33.94
35.03
Owners
Insiders/Inst%
8.24
69.11
Short interest%
4.36
SBC / revenue%
3.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
7–11
$1 testx
0.0
Incr. ROIC%
9